Myasthenia Gravis Clinical Trials in Los Angeles, California

4 studies are recruiting for myasthenia gravis in Los Angeles, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases

   The goal of this clinical study is to learn more about the study drug Anitocabtagene autoleucel (anito-cel), and its safety, tolerability, dosing, and preliminary effectiveness in participants with generalized myasthenia gravis (GMG). Anito-cel is a B-cell maturation antigen (BCMA)-directed CAR-T c…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Ronald Reagan UCLA Medical Center, Los Angeles, California

   Locations

   14 in total

   Run by

   Kite, A Gilead Company

   See if you can join NCT06626919 on ClinicalTrials.gov

2. A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

   The purpose of this study is to determine the effect of nipocalimab on total serum immunoglobulin G (IgG) in pediatric participants 2 to less than (<) 18 years of age (globally) and 8 to <18 years of age (for Unites Stated (US) sites only), the safety and tolerability of treatment with nipocalimab …

   Stage

   Phase 2

   Ages

   2 to 17

   Site

   Childrens Hospital Los Angeles, Los Angeles, California

   Locations

   19 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT05265273 on ClinicalTrials.gov

3. KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

   A Study of the Anti-CD 19 Chimeric Antigen Receptor T Cell Therapy for Patients with Myasthenia Gravis

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Ronald Reagan UCLA Medical Center, Los Angeles, California

   Locations

   22 in total

   Run by

   Kyverna Therapeutics

   See if you can join NCT06193889 on ClinicalTrials.gov

4. A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

   The purpose of this study is to evaluate the efficacy and safety of nipocalimab compared to placebo in participants with generalized myasthenia gravis (gMG). The purpose of the subcutaneous substudy is to evaluate how well it works in the body (pharmacodynamic [PD]) when given as an injection under…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   University of Southern California, Los Angeles, California

   Locations

   112 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT04951622 on ClinicalTrials.gov